Active Startup: Corbin Therapeutics Inc.

News

Published: 10Oct2019

Business Snapshot
Using a unique drug discovery platform to identify and develop novel inhibitors for treatment of various inflammation diseases, such as multiple sclerosis. This platform includes several in-vitro and in-vivo models for efficient drug screening and confirmation of potential lead candidates.

Target Markets
Inflammation (neuro-inflammation in particular)

Intellectual Property
Granted in Europe, in prosecution elsewhere.

Founder
Philippe Gros

Back to top